Analysis under consideration: Sophiris Bio, Inc. (NASDAQ:SPHS)


Sophiris Bio, Inc. (NASDAQ:SPHS)

The Company gained 35.84% and finished at $5.95. The daily volume was measured at 9.16 million shares. The 52-week high of the share price is $5.98 and the 52-week low is $0.67. The company has a market cap of $111.92 million. Its latest closing price has a distance of 122.22% from SMA20 and is 220.39 up than SMA50. SPHS is currently showing ROA (Return on Assets) value of -116.3% where ROE (Return on Equity) is -391.9%.

Return on equity (ROE) measures the rate of return on the ownership interest (shareholders’ equity) of the common stock owners. It measures a firm’s efficiency at generating profits from every unit of shareholders’ equity (also known as net assets or assets minus liabilities).

SPHS is currently showing 18.81 million shares outstanding as compared with the 18.81 million total shares float.

The Stock has its Beta Value of 1.49 and ATR (Average True Range) of 0.5. The Weekly and Monthly Volatility of the stock are 26.32% and 14.63% respectively. The weekly performance of the company stands at 90.71 percent while it’s 1-month and 3-month returns are 214.81 percent and 354.2 percent.

By looking at Sophiris Bio, Inc. (SPHS) YTD (year to date) performance, the stock shows Positive value of 234.27%. If the YTD value is Negative, it means that the stock is trading poorly. If the YTD value is Positive, this means the stock is appreciating.

The High price target of the company’s Share is at $5 based on the calculations and analysis of 2 brokers. According to the analysts, the company has the Low Price target of $4 whereas, the Mean Target is estimated by the brokers is $4.5.

For an overview on Recommendation Trends, 0 Analysts assigned the stock as Strong Buy. 2 said it’s a Buy, 0 assigned Hold rating where 0 stated the stock as Underperform and 0 marked the stock as Sell.